190 related articles for article (PubMed ID: 22382901)
1. Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.
Wei Z; Satram-Maharaj T; Chaharyn B; Kuski K; Pennington PR; Cao X; Chlan J; Mousseau DD
J Neural Transm (Vienna); 2012 Nov; 119(11):1285-94. PubMed ID: 22382901
[TBL] [Abstract][Full Text] [Related]
2. Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase-A activity.
Cao X; Rui L; Pennington PR; Chlan-Fourney J; Jiang Z; Wei Z; Li XM; Edmondson DE; Mousseau DD
J Neurochem; 2009 Oct; 111(1):101-10. PubMed ID: 19650872
[TBL] [Abstract][Full Text] [Related]
3. Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
J Neural Transm (Vienna); 2012 Apr; 119(4):405-14. PubMed ID: 22065207
[TBL] [Abstract][Full Text] [Related]
4. Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection.
Naoi M; Maruyama W; Akao Y; Yi H; Yamaoka Y
J Neural Transm Suppl; 2006; (71):67-77. PubMed ID: 17447417
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells.
Fitzgerald JC; Ufer C; De Girolamo LA; Kuhn H; Billett EE
J Neurochem; 2007 Dec; 103(6):2189-99. PubMed ID: 17883400
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation.
Ugun-Klusek A; Theodosi TS; Fitzgerald JC; Burté F; Ufer C; Boocock DJ; Yu-Wai-Man P; Bedford L; Billett EE
Redox Biol; 2019 Jan; 20():167-181. PubMed ID: 30336354
[TBL] [Abstract][Full Text] [Related]
7. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.
Geha RM; Rebrin I; Chen K; Shih JC
J Biol Chem; 2001 Mar; 276(13):9877-82. PubMed ID: 11134050
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase-A physically interacts with presenilin-1(M146V) in the mouse cortex.
Wei Z; Gabriel GG; Rui L; Cao X; Pennington PR; Chlan-Fourney J; Nazarali AJ; Baker GB; Mousseau DD
J Alzheimers Dis; 2012; 28(2):403-22. PubMed ID: 22045496
[TBL] [Abstract][Full Text] [Related]
9. Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: possible influence by distinct signalling pathways.
Cao X; Li XM; Mousseau DD
Life Sci; 2009 Jul; 85(5-6):262-8. PubMed ID: 19539632
[TBL] [Abstract][Full Text] [Related]
10. Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.
Inaba-Hasegawa K; Shamoto-Nagai M; Maruyama W; Naoi M
J Neural Transm (Vienna); 2017 Sep; 124(9):1055-1066. PubMed ID: 28577058
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines.
Wu HF; Chen K; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):888-93. PubMed ID: 8316221
[TBL] [Abstract][Full Text] [Related]
12. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
13. Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis.
Trouche E; Mias C; Seguelas MH; Ordener C; Cussac D; Parini A
Stem Cells Dev; 2010 Oct; 19(10):1571-8. PubMed ID: 20073575
[TBL] [Abstract][Full Text] [Related]
14. Arginine-42 and threonine-45 are required for FAD incorporation and catalytic activity in human monoamine oxidase B.
Kirksey TJ; Kwan SW; Abell CW
Biochemistry; 1998 Sep; 37(35):12360-6. PubMed ID: 9724550
[TBL] [Abstract][Full Text] [Related]
15. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis.
Cesura AM; Gottowik J; Lahm HW; Lang G; Imhof R; Malherbe P; Röthlisberger U; Da Prada M
Eur J Biochem; 1996 Mar; 236(3):996-1002. PubMed ID: 8665924
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.
Pennington PR; Wei Z; Rui L; Doig JA; Graham B; Kuski K; Gabriel GG; Mousseau DD
J Neural Transm (Vienna); 2011 Jul; 118(7):987-95. PubMed ID: 21373759
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis at a highly conserved tyrosine in monoamine oxidase B affects FAD incorporation and catalytic activity.
Zhou BP; Lewis DA; Kwan SW; Kirksey TJ; Abell CW
Biochemistry; 1995 Jul; 34(29):9526-31. PubMed ID: 7626622
[TBL] [Abstract][Full Text] [Related]
19. The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells.
Zarmouh NO; Messeha SS; Mateeva N; Gangapuram M; Flowers K; Eyunni SVK; Zhang W; Redda KK; Soliman KFA
Molecules; 2020 May; 25(9):. PubMed ID: 32403270
[TBL] [Abstract][Full Text] [Related]
20. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
